Clinical Trials Directory

Trials / Completed

CompletedNCT00301262

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

A Multi-Center, Parallel Group, Flexible Dose Trial With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Assess The Impact Of Viagra On The Sexual Satisfaction Of Men With Mild Erectile Dysfunction

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
183 (actual)
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Men's quality of life (QoL) is potentially affected by mild erectile dysfunction (ED) to the same extent as it is by moderate and severe ED. This study will provide controlled clinical data measuring efficacy, QoL parameters and satisfaction changes in men with mild ED treated with Viagra versus those treated with a placebo. With an open-label extension, this study will also provide all study subjects the opportunity to receive the active drug treatment for 6 weeks.

Conditions

Interventions

TypeNameDescription
DRUGViagra (Sildenafil citrate)

Timeline

Start date
2005-11-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2006-03-10
Last updated
2021-02-01
Results posted
2008-12-09

Locations

26 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT00301262. Inclusion in this directory is not an endorsement.